BSE filing, NSE: AKSHAR. Summary written from the filing by ALFA Finder's alert engine.
Akshar Spintex Ltd: key numbers
- Share price
- ₹0.42
- Market cap
- ₹33.07 Cr
- Revenue (annual)
- ₹117.3 Cr
- Net profit (annual)
- ₹-7.39 Cr
- P/E (TTM)
- -10.1×Sector 49.5×
- Promoter holding
- 0.27%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Akshar Spintex Ltd
All →Akshar Spintex Q2 FY27 Results: Turns Profitable, Net Profit ₹0.3 Cr
Akshar Spintex Ltd reported revenue from operations of ₹35.7 Cr (+60.1% YoY) and net profit of ₹0.3 Cr for Q2 FY27.
- Key figure
- Net profit ₹0.3 Cr
Akshar Spintex Board Meeting Date
Akshar Spintex has scheduled a board meeting on 27 October 2026 to consider Q1 FY27 unaudited standalone financial results and other business. Nomaterial decisions reported yet.
Akshar Spintex Annual General Meeting
Akshar Spintex Limited conducted its 13th Annual General Meeting on September 28, 2026. Key business included auditor appointments and approval of executive remuneration packages.
Akshar Spintex Annual General Meeting
Akshar Spintex Limited issued a notice for its 13th Annual General Meeting scheduled for September 28, 2026, via video conferencing to transact ordinary and special business.
Akshar Spintex Annual Report
Akshar Spintex Ltd has released its Annual Report and notice for the 13th Annual General Meeting. The meeting is scheduled for September 28, 2026, via video conferencing.
Akshar Spintex Board Meeting Outcome
Akshar Spintex Limited's board approved the appointment of H. Jamnadas & Company as Statutory Auditors. The meeting also confirmed the 13th AGM for September 28, 2026.
- Value
- ₹0.57 Cr
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.